Table 4 Multivariate analysis Parameters... | American Society of Hematology

Table 4

Multivariate analysis

Parameters in model	HR (95% CI)	P
Survival reference (OS)*
IGHV mutation status (reference: M-CLL)	6.91 (1.92-24.87)	.003
CL1^HICL3^LO (ref: all other groups combined)	5.26 (1.95-14.21)	.001
Treatment (TTFT)†
IGHV mutation status (reference: M-CLL)	2.90 (1.36-6.19)	.0059
CL1^HICL2^LO (reference: all other groups combined)	6.12 (2.48-15.10)	< .0001

Parameters in model	HR (95% CI)	P
Survival reference (OS)*
IGHV mutation status (reference: M-CLL)	6.91 (1.92-24.87)	.003
CL1^HICL3^LO (ref: all other groups combined)	5.26 (1.95-14.21)	.001
Treatment (TTFT)†
IGHV mutation status (reference: M-CLL)	2.90 (1.36-6.19)	.0059
CL1^HICL2^LO (reference: all other groups combined)	6.12 (2.48-15.10)	< .0001

OS indicates overall survival.

TTFT indicates time-to-first treatment.